Piramal Pharma Ltd.

NSE: PPLPHARMA | BSE: 543635 | ISIN: INE0DK501011 | Industry: Pharmaceuticals
| Mid-range Performer
192.8200 0.07 (0.04%)
NSE Aug 25, 2025 15:31 PM
Volume: 2.8M
 

192.82
0.04%
Motilal Oswal
Piramal Pharma (PIRPHARM) exhibited lower-than-expected financial performance in 1QFY26. Lower CDMO and complex hospital generics (CHG) sales led to a considerable operating deleverage.
Number of FII/FPI investors decreased from 257 to 247 in Jun 2025 qtr
More from Piramal Pharma Ltd.
Recommended